<?xml version="1.0" encoding="UTF-8"?>
<p>Furthermore, if we want to enhance the efficacy of the vaccine we should combine the inactivated virus with a good adjuvant. The adjuvant might contain saponins of 
 <italic>Quillaja saponaria</italic> Molina, which induce antibodies of desired subtypes, promote both the cytotoxic antiviral CD8
 <sup>+</sup> and CD4
 <sup>+</sup> Th1 cell responses against the infection and that been used with success in vaccines against leishmaniasis (
 <xref rid="B7" ref-type="bibr">7</xref>, 
 <xref rid="B27" ref-type="bibr">27</xref>, 
 <xref rid="B28" ref-type="bibr">28</xref>), cancer (
 <xref rid="B29" ref-type="bibr">29</xref>), Malaria (
 <xref rid="B30" ref-type="bibr">30</xref>), Herpes zoster (
 <xref rid="B31" ref-type="bibr">31</xref>), and HIV (
 <xref rid="B32" ref-type="bibr">32</xref>).
</p>
